Related Experiment Video
Updated: Aug 25, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding
Eilyn R Lacy1, Igor Filippov, William S Lewis
1Department of Structural Biology, St. Jude Children's Research Hospital, 332, North Lauderdale Street, Memphis, Tennessee 38105, USA.
Abstract:
p27 controls cell proliferation by binding and regulating nuclear cyclin-dependent kinases (CDKs). In addition, p27 interacts with other nuclear and cytoplasmic targets and has diverse biological functions. We seek to understand how the structural and dynamic properties of p27 mediate its several functions. We show that, despite showing disorder before binding its targets, p27 has nascent secondary structure that may have a function in molecular recognition. Binding to Cdk2-cyclin A is accompanied by p27 folding, and kinetic data suggest a sequential mechanism that is initiated by binding to cyclin A. p27 regulates CDK-cyclin complexes involved directly in cell cycle control and does not interact with other closely related CDKs. We show that p27-cyclin interactions are an important determinant of this specificity and propose that the homologous cell cycle regulators p21 and p57 function by a similar sequential, folding-on-binding mechanism.
Insights
The protein p27 regulates cell proliferation by binding to cyclin-dependent kinases (CDKs). This study reveals p27 has nascent secondary structures and folds upon binding, a mechanism key to its cell cycle control functions.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The protein p27 (also known as CDKN1B) is a key regulator of cell proliferation.
- It functions by inhibiting nuclear cyclin-dependent kinases (CDKs), which are critical for cell cycle progression.
- p27 also interacts with various other cellular targets, indicating diverse biological roles.
Purpose of the Study:
- To elucidate the structural and dynamic properties of p27 that underpin its multifaceted functions.
- To understand the molecular mechanisms by which p27 interacts with its targets, particularly CDK-cyclin complexes.
Main Methods:
- Investigated the structural characteristics of p27, including its intrinsic disorder and nascent secondary structure.
- Utilized kinetic analyses to determine the mechanism of p27 binding to Cdk2-cyclin A.
- Examined the specificity of p27 interactions with different CDK-cyclin complexes.
Main Results:
- p27 exhibits intrinsic disorder but possesses nascent secondary structure that may aid in molecular recognition.
- Binding to Cdk2-cyclin A induces p27 folding, with kinetics suggesting an initial interaction with cyclin A.
- p27 specifically targets CDK-cyclin complexes involved in cell cycle control, not closely related CDKs.
Conclusions:
- p27's interaction with cyclin A is crucial for its specificity and function in regulating cell cycle progression.
- The findings suggest a sequential, folding-on-binding mechanism for p27's activity.
- Homologous proteins p21 and p57 likely employ similar mechanisms for their cell cycle regulatory functions.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
Anaphase Promoting Complex
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...